Bid Publish Date
29-Jan-2025, 2:19 pm
Bid End Date
24-Feb-2025, 9:00 am
Location
Progress
Quantity
61674
Bid Type
Two Packet Bid
Indian Army has released a public tender for Bilastine 20mg Dispersible Tab, Inj Etophyllne 84. 7 plus Theophylline 25. 3 ml, Tolperisone SR 150mg Tab, Syp Paracetamol 162mg plus Ibuprofen 100mg 60ml, Inj Methylcobalamin 1500 mcg, Dexamethasone 4mg Tab, Nicorandil 5mg Tab in CENTRAL DELHI, DELHI. Quantity: 61674. Submission Deadline: 24-02-2025 09: 00: 00. Download documents and apply online.
Tender Category
Goods
Bid To RA
No
Bid To RA Enabled
No
Item Category
Bilastine 20mg Dispersible Tab , Inj Etophyllne 84.7 plus Theophylline 25.3 ml , Tolperisone SR 150mg Tab , Syp Paracetamol 162mg plus Ibuprofen 100mg 60ml , Inj Methylcobalamin 1500 mcg , Dexamethasone 4mg Tab , Nicorandil 5mg Tab
End-to-end support — bid preparation, GeM registration, document filing & compliance by industry experts.
Free consultation · 24h response
Main Document
BOQ
BOQ
ATC
OTHER
Discover companies most likely to bid on this tender
Experience Criteria
Past Performance
Bidder Turnover
Certificate (Requested in ATC)
OEM Authorization Certificate
OEM Annual Turnover
Compliance of BoQ specification and supporting document *In case any bidder is seeking exemption from Experience / Turnover Criteria
the supporting documents to prove his eligibility for exemption must be uploaded for evaluation by the buyer
Extended Deadline
24-Feb-2025, 9:00 am
Opening Date
24-Feb-2025, 9:30 am
Key insights about DELHI tender market
The eligibility requirements include being a registered entity with proven experience in supplying pharmaceutical products. Bidders must provide supporting documents such as OEM authorization certificates, past performance documentation, and compliance certificates with relevant health regulations. Financial stability, evidenced by submitted financial statements, is also necessary. Additionally, bidders may qualify for exemptions from specific experience and turnover criteria if they provide adequate justification and supporting documents.
To successfully participate, bidders must submit various documents including past performance certificates, OEM authorization, and compliance documents. Other required papers include financial statements, adherence to specifications outlined in the BoQ, and any exemption request documents that justify relief from certain eligibility criteria. All submissions must be made in the specified electronic formats as outlined in the tender documentation.
Bidders must comply with specific technical specifications prescribed in the tender documentation, ensuring that products meet the quality standards of relevant regulatory bodies. This includes confirmation of active ingredients, dosage forms, and packaging standards. Submissions should also demonstrate compliance with health safety standards, which are critical for pharmaceutical procurement.
The payment terms involve invoicing upon delivery and acceptance of the products, with specific timelines for payment processing detailed in the contract terms. To ensure compliance and product delivery, successful bidders may be required to submit a performance security, typically a percentage of the contract value, safeguarded against non-fulfillment of obligations.
The evaluation process will take place on an item-wise basis focusing on quality, compliance with specifications, and price considerations. Each bid will undergo thorough scrutiny, ensuring that all submissions are compliant with the eligibility requirements. Notification of results will be communicated to all bidders post-evaluation, detailing the outcomes and any necessary next steps for successful candidates.
Sign up now to access all documents
Main Document
BOQ
BOQ
ATC
OTHER